BioSig Announces Submission of FDA 510(k) Application for PURE EP™ System

NEXT STORY
Wearable Fitness Trackers Market to Reach $48.2 Billion by 2023: P&S Market Research
PREV STORY
Novartis to present predictability data for brolucizumab in nAMD from pivotal HAWK and HARRIER trials at ARVO
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

vTv Therapeutics Announces Results of Multiple Ascending Dose Study and Development Plan for HPP737, an Oral PDE4 Inhibitor for the Treatment of Psoriasis

author_avatar
NASDAQ Market News

Mateon and Oncotelic Complete Their Merger and Create a New Immuno-Oncology Company with a Late-Stage Clinical Asset Against Cancer and a Promising Product Pipeline

author_avatar
NASDAQ Market News

Global Molecular Diagnostics Market Forecasts to 2026 – Point-of-Care (POC) Segment is Expected to Witness the Fastest Growth over the Forecast Period

author_avatar
NASDAQ Market News